CXCR4 and neoplasm: As shown in Figures 4B and 4C, injection of the FL cytokine expanded over 2-fold (p < 0.05) the frequency of CD103+ DCs among the MHCII+F4/80loCD24hi cell population in both OVV and OVV-CXCR4-A-treated tumor-bearing mice (Figures 4B–4E).